SHR-1701 in Metastatic or Locally Advanced Solid Tumors

NCT03710265 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: SHR-1701

Sponsor

Jiangsu HengRui Medicine Co., Ltd.